JP Morgan Chase’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

JP Morgan Chase’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-350,838	Closed	-$16.1M	–	4358
2015 Q1	$16.1M	Buy	+350,838	New	+$10.5M	﹤0.01%	1589
2014 Q4	–	Sell	-24,884	Closed	-$628K	–	4512
2014 Q3	$628K	Sell	24,884 -79	-0.3%	-$1.96K	﹤0.01%	3562
2014 Q2	$652K	Buy	+24,963	New	+$642K	﹤0.01%	3028
2014 Q1	–	Sell	-238,519	Closed	-$4.82M	–	4177
2013 Q4	$4.82M	Sell	238,519 -12,475	-5%	-$294K	﹤0.01%	2197
2013 Q3	$6.56M	Buy	250,994 +3,224	+1%	+$80.7K	﹤0.01%	2016
2013 Q2	$5.45M	Buy	+247,770	New	+$5.43M	﹤0.01%	2080

JP Morgan Chase's HPTX Position: Q2 2015 in Review

JP Morgan Chase sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 350,838 shares — an estimated $16.1M sold.

JP Morgan Chase first reported a position in HPTX in Q2 2013 and held it in 6 quarters. The position peaked at $16.1M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

JP Morgan Chase reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
JP Morgan Chase sold 350,838 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $16.1M.
JP Morgan Chase first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
JP Morgan Chase's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $16.1M in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.